***PKTX.. PROTOKINETIX, INCORPORATED. 9176 South Pleasants Highway St. Marys, WV 26170
..ProtoKinetix Announces New President and Chief Executive Officer
February 23, 2015
...ProtoKinetix, Incorporated (OTC: PKTX) (www.protokinetix.com) (the "Company" or "ProtoKinetix") announces that a cease trade order issued by the British Columbia Securities Commission was revoked effective as of the date of this news release.
..In connection with the revocation, the Company also announces that it has received and accepted the resignation of Mr. Ross Senior as a Director, President and Chief Executive Officer of the Company effective as of February 19, 2015. Mr. Clarence E. Smith has been appointed as the Company's new President and Chief Executive Officer.
..ProtoKinetix further announces that it has moved its head office to 9176 South Pleasants Highway, St. Marys, West Virginia, USA 26170.
About ProtoKinetix
ProtoKinetix is a molecular biotechnology company that has developed and patented a family of hyper stable, potent glycopeptides (AAGP™) that dramatically enhance the therapeutic results and reduce the cost of stem cell medicine. Due to the anti-inflammatory effect of AAGP™ molecules, the Company is currently targeting the direct treatment of diseases that have a major inflammatory component. ON BEHALF OF THE BOARD OF DIRECTORS PROTOKINETIX, INCORPORATED Clarence E. Smith President and Chief Executive Officer For further information, please contact: Clarence E. Smith, President & Chief Executive Officer Telephone: 304-299-5070 Email: csmith@protokinetix.com